Navigation Links
Varian Medical Systems to Showcase New X-Ray Tubes and Flat Panel Detectors at the ECR Annual Meeting
Date:3/3/2011

SALT LAKE CITY, March 3, 2011 /PRNewswire/ -- ECR Booth #313/Expo C - Varian Medical Systems, Inc., X-Ray Products, will be showcasing a comprehensive imaging portfolio of PaxScan® digital image detectors and X-ray tubes for fluoroscopy, angiography, cardiology and cone-beam CT imaging at the European Congress of Radiology (ECR) annual  meeting in Vienna, Austria this week.  

"Our exhibit reflects our commitment to the industry's demands for technically advanced X-ray tube and flat panel solutions," said Steve Kimmel, vice president of Sales and Marketing for Varian X-Ray Products.  "The new panel and tube platforms offer a path to improve image quality, greater cost efficiency, and potential for increased patient throughput."

The products to be highlighted at ECR are:

  • The new M-1500, Varian's first X-ray tube developed specifically for advanced mammography applications such as tomosynthesis and CT.  The M-1500 provides exceptional performance in a space efficient design.  "This revolutionary design provides for high throughput and performance in specialized mammography applications," said Dennis Runnoe, vice president of Research and Development Engineering.
  • The new PaxPower FP X-ray tube which is optimized for interventional procedures and portable surgical CT systems.  The new PaxPower FP tube platforms were developed with a smaller footprint and higher power. "This new technology represents a new generation of diagnostic tubes incorporating much of what we have learned over years of anode-grounded CT development.  This new tube technology provides a dramatically smaller and lighter package with higher heat dissipation allowing for higher patient throughput," said Kimmel.
  • The new PaxScan® 3024M flat panel detector designed for full field digital mammography.  The compact design, incorporating a narrow edge and rapid image-acquisition capabilities, enables radiologists to
    '/>"/>

  • SOURCE Varian Medical Systems, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
    2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
    3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
    4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
    5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
    6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
    7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
    8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
    9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
    10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
    11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/3/2015)... , August 3, 2015 ... announced today that it has acquired ... Inc. for $300 million. With the acquisition, Shire ... drops combining 0.6% povidone iodine (PVP-I) and 0.1% ... treatment of infectious conjunctivitis, an ocular surface condition ...
    (Date:8/2/2015)... Mandatory takeover offer for ... or the "Company") is pleased to announce the signing ... Marijan Han žeković to acquire his 63.3% holding ... a Croatian listed pharmaceutical business.   Dechra ... to €51.4 million for the entire share capital on ...
    (Date:7/31/2015)... HILL, N.C. , July 31, 2015  In ... of customers who are increasingly mobile, increasingly connected, and ... a growing variety of customer interaction channels and tools ... technology, including social media. According to ... the over the counter (OTC) segment in a call ...
    Breaking Medicine Technology:Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 2Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 3Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 5Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 6Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 2Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 3Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 5Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2
    ... Health, Inc. (Nasdaq: GHDX ) today announced plans ... improving the quality of diagnosis, communication and support for millions ... genetic conditions.   The subsidiary is expected to be established by ... 2013.  The new venture will be led by Randy Scott, ...
    ... 2012 TeDan Surgical Innovations , industry leader ... Phantom Series MIS Anterior Hip Retractor System . ... adjustable surgical arms with attachable retractors, enabling surgeons to ... a surgical assistant. Dr. Lawrence Menendez ...
    Cached Medicine Technology:Genomic Health Announces Formation of New Genetics Subsidiary 2Genomic Health Announces Formation of New Genetics Subsidiary 3Genomic Health Announces Formation of New Genetics Subsidiary 4New Minimally Invasive Hip Retractor Revolutionizes Anterior Hip Replacement Procedures 2
    (Date:8/3/2015)... ... 2015 , ... Code , an industry leader of image-based barcode reading ... Reader accessory that enables a wireless connection between the CR5000 and a ... of barcode reading applications with iPads, Galaxy Tabs, and many other products that lack ...
    (Date:8/3/2015)... ... August 03, 2015 , ... Bayer has agreed to pay $56.9 million to ... a claimant alleged to have suffered an arterial blood clot including stroke and heart ... Yasmin and Ocella, has been ongoing for well-over five years. In 2009, lawsuits filed ...
    (Date:8/3/2015)... , ... August 03, 2015 , ... ... agreement to Seattle-based Genelex to offer pharmacogenetic lab testing and precision medicine solutions ... health care costs. , Annually, more than 8.6 million adverse drug events ...
    (Date:8/3/2015)... ... August 03, 2015 , ... Social ... , AUGUST 3, 2015 – Since winning a South by Southwest® (SXSW®) Interactive ... – an organization whose mission is to develop technology for the sake of ...
    (Date:8/3/2015)... ... August 03, 2015 , ... Sensato and ... Secure Healthcare Systems” This three-day, highly interactive and immersive workshop, has been ... access to the tactics, techniques and practices required to design and develop highly ...
    Breaking Medicine News(10 mins):Health News:Code Launches the T500, an Innovative Code Reader Accessory 2Health News:Code Launches the T500, an Innovative Code Reader Accessory 3Health News:Bayer Agrees To Settle Yaz Aterial Blood Clot Lawsuits 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4
    ... recovering from heart problems, but have depression take longer ... a treadmill stress test, according to a new study ... Dr. Joel W. Hughes, of Kent State University, Ohio, ... recover from the stress test have increased mortality risk. ...
    ... to naught. Apart from the ordeal of suffering a naughty child, ... an awfully expensive proposition for the parents and for the society ... to the parents, the NHS, social services and schools to the ... ,But the most part of the ordeal is faced by the ...
    ... currently on a visit to Riyadh, has declared that ... center for the All India Engineering Entrance Examination (AIEEE) ... of equivalence of degrees will cease to be a ... Muslim University Old Boys' Association (AMUOBA), which had organised ...
    ... Karen Johnstone, 28, was suffering from Deep Vein Thrombosis since ... away after doctors told her that she no longer suffered ... a blood clot that had formed in her legs moved ... her lungs. ,Kathy and Norman, Karen’s parents, absolutely devastated ...
    ... on the worries experienced by long-term survivors reveals the ... treatment//, a second cancer and a shortened life will ... the thoughts of approximately one-third of long-term, older-adult cancer ... Survivor Research Project reports. ,It may ...
    ... increases the concentration, abstract reasoning and verbal skills in ... must be interpreted with caution//. ,Mark Espeland ... Center in the US studied more than 7,000 older ... amount of alcohol have slightly higher levels of mental ...
    Cached Medicine News:Health News:After Cancer Treatment Worry Continues – Researchers Find 2Health News:After Cancer Treatment Worry Continues – Researchers Find 3
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: